APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Donepezil Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Donepezil Drug Industry Growth and Trends Forecast to 2032

Report ID 173985610129 December 2025100 pages

Choose your research edition.

Industry ResearchDonepezil Drug Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Donepezil Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Donepezil Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Donepezil Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Donepezil Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Donepezil Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Donepezil Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Donepezil Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Donepezil Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Donepezil Drug include Eisai, Teva, Sun Pharmaceutical, Novartis, Pfizer, Luoxin, Jishengtang Pharma, Hansoh Pharma and Dr Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Donepezil Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Donepezil Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Donepezil Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Donepezil Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Donepezil Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Donepezil Drug Market by Company

Eisai

Teva

Sun Pharmaceutical

Novartis

Pfizer

Luoxin

Jishengtang Pharma

Hansoh Pharma

Dr Reddy's Laboratories

Cipla

ARK PHA.LTD

Apotex

Donepezil Drug Segment by Type

5mg

10mg

23mg

Donepezil Drug Segment by Application

Hospitals

Clinics

Drugstore

Donepezil Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Donepezil Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Donepezil Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Donepezil Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5mg Table 2. Major Company of 10mg Table 3. Major Company of 23mg Table 4. Global Donepezil Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Donepezil Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Donepezil Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Donepezil Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Donepezil Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Donepezil Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Donepezil Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Donepezil Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Donepezil Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Donepezil Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Donepezil Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Donepezil Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Donepezil Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Donepezil Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Donepezil Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Donepezil Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Donepezil Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Donepezil Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Donepezil Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Donepezil Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Donepezil Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Donepezil Drug Industry Trends Table 26. Donepezil Drug Industry Drivers Table 27. Donepezil Drug Industry Opportunities and Challenges Table 28. Donepezil Drug Industry Restraints Table 29. Global Donepezil Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Donepezil Drug Revenue Market Share by Company (2021-2026) Table 31. Global Donepezil Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Donepezil Drug Sales Share by Company (2021-2026) Table 33. Global Donepezil Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Donepezil Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Donepezil Drug Major Company Production Sites and Headquarters Table 36. Global Donepezil Drug Company, Product Type & Application Table 37. Global Donepezil Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Donepezil Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Donepezil Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Donepezil Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Donepezil Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Donepezil Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Donepezil Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Donepezil Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Donepezil Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Donepezil Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Donepezil Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Donepezil Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Donepezil Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Donepezil Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Donepezil Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Donepezil Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Donepezil Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Donepezil Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Donepezil Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Donepezil Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Donepezil Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Donepezil Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Donepezil Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Donepezil Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Donepezil Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Donepezil Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Donepezil Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Donepezil Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Donepezil Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Donepezil Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Donepezil Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Donepezil Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Donepezil Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Donepezil Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Eisai Company Information Table 73. Eisai Business Overview Table 74. Eisai Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Eisai Donepezil Drug Product Portfolio Table 76. Eisai Recent Development Table 77. Teva Company Information Table 78. Teva Business Overview Table 79. Teva Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Teva Donepezil Drug Product Portfolio Table 81. Teva Recent Development Table 82. Sun Pharmaceutical Company Information Table 83. Sun Pharmaceutical Business Overview Table 84. Sun Pharmaceutical Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sun Pharmaceutical Donepezil Drug Product Portfolio Table 86. Sun Pharmaceutical Recent Development Table 87. Novartis Company Information Table 88. Novartis Business Overview Table 89. Novartis Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Novartis Donepezil Drug Product Portfolio Table 91. Novartis Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pfizer Donepezil Drug Product Portfolio Table 96. Pfizer Recent Development Table 97. Luoxin Company Information Table 98. Luoxin Business Overview Table 99. Luoxin Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Luoxin Donepezil Drug Product Portfolio Table 101. Luoxin Recent Development Table 102. Jishengtang Pharma Company Information Table 103. Jishengtang Pharma Business Overview Table 104. Jishengtang Pharma Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Jishengtang Pharma Donepezil Drug Product Portfolio Table 106. Jishengtang Pharma Recent Development Table 107. Hansoh Pharma Company Information Table 108. Hansoh Pharma Business Overview Table 109. Hansoh Pharma Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Hansoh Pharma Donepezil Drug Product Portfolio Table 111. Hansoh Pharma Recent Development Table 112. Dr Reddy's Laboratories Company Information Table 113. Dr Reddy's Laboratories Business Overview Table 114. Dr Reddy's Laboratories Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Dr Reddy's Laboratories Donepezil Drug Product Portfolio Table 116. Dr Reddy's Laboratories Recent Development Table 117. Cipla Company Information Table 118. Cipla Business Overview Table 119. Cipla Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Cipla Donepezil Drug Product Portfolio Table 121. Cipla Recent Development Table 122. ARK PHA.LTD Company Information Table 123. ARK PHA.LTD Business Overview Table 124. ARK PHA.LTD Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. ARK PHA.LTD Donepezil Drug Product Portfolio Table 126. ARK PHA.LTD Recent Development Table 127. Apotex Company Information Table 128. Apotex Business Overview Table 129. Apotex Donepezil Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Apotex Donepezil Drug Product Portfolio Table 131. Apotex Recent Development Table 132. North America Donepezil Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. North America Donepezil Drug Sales by Country (2021-2026) & (K Units) Table 134. North America Donepezil Drug Sales Market Share by Country (2021-2026) Table 135. North America Donepezil Drug Sales Forecast by Country (2027-2032) & (K Units) Table 136. North America Donepezil Drug Sales Market Share Forecast by Country (2027-2032) Table 137. North America Donepezil Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Donepezil Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Donepezil Drug Market Share by Country (2021-2026) Table 140. North America Donepezil Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Donepezil Drug Market Share Forecast by Country (2027-2032) Table 142. Europe Donepezil Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Europe Donepezil Drug Sales by Country (2021-2026) & (K Units) Table 144. Europe Donepezil Drug Sales Market Share by Country (2021-2026) Table 145. Europe Donepezil Drug Sales Forecast by Country (2027-2032) & (K Units) Table 146. Europe Donepezil Drug Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Donepezil Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Donepezil Drug Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Donepezil Drug Market Share by Country (2021-2026) Table 150. Europe Donepezil Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Donepezil Drug Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Donepezil Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Donepezil Drug Sales by Country (2021-2026) & (K Units) Table 154. Asia-Pacific Donepezil Drug Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Donepezil Drug Sales Forecast by Country (2027-2032) & (K Units) Table 156. Asia-Pacific Donepezil Drug Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Donepezil Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Donepezil Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Donepezil Drug Market Share by Country (2021-2026) Table 160. Asia-Pacific Donepezil Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Donepezil Drug Market Share Forecast by Country (2027-2032) Table 162. Latin America Donepezil Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Latin America Donepezil Drug Sales by Country (2021-2026) & (K Units) Table 164. Latin America Donepezil Drug Sales Market Share by Country (2021-2026) Table 165. Latin America Donepezil Drug Sales Forecast by Country (2027-2032) & (K Units) Table 166. Latin America Donepezil Drug Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Donepezil Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Donepezil Drug Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Donepezil Drug Market Share by Country (2021-2026) Table 170. Latin America Donepezil Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Donepezil Drug Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Donepezil Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Donepezil Drug Sales by Country (2021-2026) & (K Units) Table 174. Middle East and Africa Donepezil Drug Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Donepezil Drug Sales Forecast by Country (2027-2032) & (K Units) Table 176. Middle East and Africa Donepezil Drug Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Donepezil Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Donepezil Drug Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Donepezil Drug Market Share by Country (2021-2026) Table 180. Middle East and Africa Donepezil Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Donepezil Drug Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Donepezil Drug Distributors List Table 185. Donepezil Drug Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Donepezil Drug Image Figure 2. Global Donepezil Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Donepezil Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Donepezil Drug Sales (2021-2032) & (K Units) Figure 5. 5mg Image Figure 6. Global 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10mg Image Figure 8. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 23mg Image Figure 10. Global 23mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Donepezil Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Donepezil Drug Market Share by Type 2025 VS 2032 Figure 13. North America Donepezil Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Donepezil Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Donepezil Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Donepezil Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Donepezil Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Donepezil Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Donepezil Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Donepezil Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Donepezil Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Donepezil Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Donepezil Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Drugstore Image Figure 30. Global Drugstore Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Donepezil Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Donepezil Drug Market Share by Application 2025 VS 2032 Figure 33. North America Donepezil Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Donepezil Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Donepezil Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Donepezil Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Donepezil Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Donepezil Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Donepezil Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Donepezil Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Donepezil Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Donepezil Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Donepezil Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Donepezil Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Donepezil Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Donepezil Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Donepezil Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Donepezil Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Donepezil Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Donepezil Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Donepezil Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Donepezil Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Donepezil Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Donepezil Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Donepezil Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Donepezil Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Donepezil Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Donepezil Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Donepezil Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Donepezil Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Donepezil Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Donepezil Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Donepezil Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Donepezil Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
  • 23mg
Applications
  • Hospitals
  • Clinics
  • Drugstore
Companies covered
  • Eisai
  • Teva
  • Sun Pharmaceutical
  • Novartis
  • Pfizer
  • Luoxin
  • Jishengtang Pharma
  • Hansoh Pharma
  • Dr Reddy's Laboratories
  • Cipla
  • ARK PHA.LTD
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Donepezil Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Donepezil Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Donepezil Drug Market by Type
  6. 1.3.1 5mg
  7. 1.3.2 10mg
  8. 1.3.3 23mg
  9. 1.4 Global Donepezil Drug Market Size by Type
  10. 1.4.1 Global Donepezil Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Donepezil Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Donepezil Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Donepezil Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Donepezil Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Donepezil Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Donepezil Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Donepezil Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Donepezil Drug Industry Trends
  2. 2.2 Donepezil Drug Industry Drivers
  3. 2.3 Donepezil Drug Industry Opportunities and Challenges
  4. 2.4 Donepezil Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Donepezil Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Donepezil Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Donepezil Drug Price (2021-2026)
  4. 3.4 Global Donepezil Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Donepezil Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Donepezil Drug Company, Product Type & Application
  7. 3.7 Global Donepezil Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Donepezil Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Donepezil Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Donepezil Drug Tier 1, Tier 2, and Tier 3
4 Donepezil Drug Regional Status and Outlook
  1. 4.1 Global Donepezil Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Donepezil Drug Historic Market Size by Region
  3. 4.2.1 Global Donepezil Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Donepezil Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Donepezil Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Donepezil Drug Forecasted Market Size by Region
  7. 4.3.1 Global Donepezil Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Donepezil Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Donepezil Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Donepezil Drug by Application
  1. 5.1 Donepezil Drug Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Drugstore
  5. 5.2 Global Donepezil Drug Market Size by Application
  6. 5.2.1 Global Donepezil Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Donepezil Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Donepezil Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Donepezil Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Donepezil Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Donepezil Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Donepezil Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Donepezil Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai
  2. 6.1.1 Eisai Company Information
  3. 6.1.2 Eisai Business Overview
  4. 6.1.3 Eisai Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Donepezil Drug Product Portfolio
  6. 6.1.5 Eisai Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Donepezil Drug Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sun Pharmaceutical
  14. 6.3.1 Sun Pharmaceutical Company Information
  15. 6.3.2 Sun Pharmaceutical Business Overview
  16. 6.3.3 Sun Pharmaceutical Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharmaceutical Donepezil Drug Product Portfolio
  18. 6.3.5 Sun Pharmaceutical Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Donepezil Drug Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Donepezil Drug Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Luoxin
  32. 6.6.1 Luoxin Company Information
  33. 6.6.2 Luoxin Business Overview
  34. 6.6.3 Luoxin Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Luoxin Donepezil Drug Product Portfolio
  36. 6.6.5 Luoxin Recent Developments
  37. 6.7 Jishengtang Pharma
  38. 6.7.1 Jishengtang Pharma Company Information
  39. 6.7.2 Jishengtang Pharma Business Overview
  40. 6.7.3 Jishengtang Pharma Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jishengtang Pharma Donepezil Drug Product Portfolio
  42. 6.7.5 Jishengtang Pharma Recent Developments
  43. 6.8 Hansoh Pharma
  44. 6.8.1 Hansoh Pharma Company Information
  45. 6.8.2 Hansoh Pharma Business Overview
  46. 6.8.3 Hansoh Pharma Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hansoh Pharma Donepezil Drug Product Portfolio
  48. 6.8.5 Hansoh Pharma Recent Developments
  49. 6.9 Dr Reddy's Laboratories
  50. 6.9.1 Dr Reddy's Laboratories Company Information
  51. 6.9.2 Dr Reddy's Laboratories Business Overview
  52. 6.9.3 Dr Reddy's Laboratories Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dr Reddy's Laboratories Donepezil Drug Product Portfolio
  54. 6.9.5 Dr Reddy's Laboratories Recent Developments
  55. 6.10 Cipla
  56. 6.10.1 Cipla Company Information
  57. 6.10.2 Cipla Business Overview
  58. 6.10.3 Cipla Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cipla Donepezil Drug Product Portfolio
  60. 6.10.5 Cipla Recent Developments
  61. 6.11 ARK PHA.LTD
  62. 6.11.1 ARK PHA.LTD Company Information
  63. 6.11.2 ARK PHA.LTD Business Overview
  64. 6.11.3 ARK PHA.LTD Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ARK PHA.LTD Donepezil Drug Product Portfolio
  66. 6.11.5 ARK PHA.LTD Recent Developments
  67. 6.12 Apotex
  68. 6.12.1 Apotex Company Information
  69. 6.12.2 Apotex Business Overview
  70. 6.12.3 Apotex Donepezil Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Apotex Donepezil Drug Product Portfolio
  72. 6.12.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Donepezil Drug Sales by Country
  2. 7.1.1 North America Donepezil Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Donepezil Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Donepezil Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Donepezil Drug Market Size by Country
  6. 7.2.1 North America Donepezil Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Donepezil Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Donepezil Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Donepezil Drug Sales by Country
  2. 8.1.1 Europe Donepezil Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Donepezil Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Donepezil Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Donepezil Drug Market Size by Country
  6. 8.2.1 Europe Donepezil Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Donepezil Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Donepezil Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Donepezil Drug Sales by Country
  2. 9.1.1 Asia-Pacific Donepezil Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Donepezil Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Donepezil Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Donepezil Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Donepezil Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Donepezil Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Donepezil Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Donepezil Drug Sales by Country
  2. 10.1.1 South America Donepezil Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Donepezil Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Donepezil Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Donepezil Drug Market Size by Country
  6. 10.2.1 South America Donepezil Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Donepezil Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Donepezil Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Donepezil Drug Sales by Country
  2. 11.1.1 Middle East and Africa Donepezil Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Donepezil Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Donepezil Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Donepezil Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Donepezil Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Donepezil Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Donepezil Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Donepezil Drug Value Chain Analysis
  2. 12.1.1 Donepezil Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Donepezil Drug Production Mode & Process
  7. 12.2 Donepezil Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Donepezil Drug Distributors
  10. 12.2.3 Donepezil Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst